Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations (Q38252636)

1 September 2017

1 reference

title

Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations (English)

1 reference

1 September 2017

0 references

4

Peter Lewindon

1 reference

1 September 2017

Oren Ledder

1

1 reference

1 September 2017

Wolfram Haller

series ordinal

2

1 reference

1 September 2017

Richard Tl Couper

series ordinal

3

1 reference

1 September 2017

Mark Oliver

series ordinal

5

1 reference

1 September 2017

publication date

1 December 2014

1 reference

Journal of Gastroenterology and Hepatology

1 September 2017

published in

1 reference

1 September 2017

volume

29

1 reference

1 September 2017

issue

12

1 reference

1 September 2017

page(s)

1954-1962

1 reference

Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease

1 September 2017

cites work

1 reference

Prevalence of liver disease in cystic fibrosis

21 January 2018

1 reference

Cholangiocyte biology and cystic fibrosis liver disease

21 January 2018

1 reference

Liver disease and bile duct abnormalities in adults with cystic fibrosis

21 January 2018

1 reference

Hepatobiliary disease in patients with cystic fibrosis

21 January 2018

1 reference

Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model

21 January 2018

1 reference

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.

21 January 2018

1 reference

Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment

21 January 2018

1 reference

Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile

21 January 2018

1 reference

Fluid flow induces mechanosensitive ATP release, calcium signalling and Cl- transport in biliary epithelial cells through a PKCzeta-dependent pathway

21 January 2018

1 reference

Genetic modifiers of liver disease in cystic fibrosis

21 January 2018

1 reference

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease

21 January 2018

1 reference

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study.

21 January 2018

1 reference

Transient elastography in patients with cystic fibrosis

21 January 2018

1 reference

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

21 January 2018

1 reference

Ursodeoxycholic acid for cystic fibrosis-related liver disease

21 January 2018

1 reference

Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series

21 January 2018

1 reference

Partial splenectomy for portal hypertension in cystic fibrosis related liver disease

21 January 2018

1 reference

Partial Splenic Embolization: successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis.

21 January 2018

1 reference

Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data

21 January 2018

1 reference

Pathology of gastrointestinal organs in a porcine model of cystic fibrosis

21 January 2018

1 reference

MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patients.

21 January 2018

1 reference

Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas

21 January 2018

1 reference

Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening

21 January 2018

1 reference

Pathogenesis of malnutrition in cystic fibrosis, and its treatment

21 January 2018

1 reference

Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders.

21 January 2018

1 reference

Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test

21 January 2018

1 reference

Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. Pediatric Gastroenterological Society and the Dietitians Association of Australia

21 January 2018

1 reference

Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency

21 January 2018

1 reference

International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.

21 January 2018

1 reference

Fibrosing colonopathy in cystic fibrosis: results of a case-control study

21 January 2018

1 reference

Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis

21 January 2018

1 reference

Drug therapies for reducing gastric acidity in people with cystic fibrosis

21 January 2018

1 reference

Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy

21 January 2018

1 reference

Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice

21 January 2018

1 reference

Omega-3 fatty acids for cystic fibrosis

21 January 2018

1 reference

Genetics of pancreatitis: an update for clinicians and genetic counselors

21 January 2018

1 reference

The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians.

21 January 2018

1 reference

Increased detection of cystic-fibrosis-related diabetes in Australia.

21 January 2018

1 reference

Hyperglycaemia and pulmonary infection

21 January 2018

1 reference

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

21 January 2018

1 reference

Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline

21 January 2018

1 reference

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

21 January 2018

1 reference

Improved screening for cystic fibrosis-related diabetes by an integrated care team using an algorithm

21 January 2018

1 reference

Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus

21 January 2018

1 reference

Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency

21 January 2018

1 reference

Independent Contribution of Common CFTR Variants to Chronic Pancreatitis

21 January 2018

1 reference

Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy

21 January 2018

1 reference

Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12785

1 reference

release_a5ehnoto3jby5jikwl3s3xhnnm

1 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a5ehnoto3jby5jikwl3s3xhnnm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference